Posmeal MD (Voglibose) is an oral hypoglycemic medication, belonging to the class of competitive alpha glucosidase inhibitors. Alpha glucosidase enzymes are involved in breaking down complex carbohydrates, such as disaccharides, oligosaccharides, and polysaccharides. The medication inhibits alpha glucosidase enzymes, slowing down the processes of complex carbohydrates breakdown and glucose absorption. Subsequently, the blood glucose level after a meal decreases. Posmeal MD (Voglibose) does not affect beta glucosidase enzymes.

Posmeal MD (Voglibose) is slowly absorbed, quickly metabolized and then eliminated from body via intestines. Blood and urine do not contain any Posmeal MD (Voglibose) metabolites.

Posmeal MD (Voglibose) is prescribed for type 2 diabetes (monotherapy or combination therapy with other hypoglycemic medications or insulin); for type 1 diabetes (combination therapy with insulin); and for type 2 diabetes prevention.

How should I use Posmeal MD (Voglibose)?

Posmeal MD (Voglibose) has to be taken right before the meal. Normally, healthcare practitioners try to avoid any adverse events and prescribe to most patients the initial dose of one 0.2mg tablet taken three times daily. It is important to note that the dose may be subsequently raised to 0.3mg taken three times daily if the initial dose was not sufficient to achieve the required therapeutic effects.

What are the side effects of Posmeal MD (Voglibose)?

Side effects are the part of the pharmacological action of the medication along with its therapeutic effects. To minimize side effects, your physician may reduce the dose, change the dosing frequency, or replace the medication with another one. Certainly, the medication as well as its safe dose are prescribed by the doctor, however the final decision on whether to take the medication or not remains with the patient.

Posmeal MD (Voglibose) has more potential side effects compared to such alpha glucosidase inhibitors as Acarbose and Miglitol, however it is also more effective. If any side effects occur in the course of the treatment, contact your physician immediately. Potential side effects may include:

Bloating

Bowel obstruction

Diarrhea

Elevated liver transaminase

Flatulence

Fulminant hepatitis

Hypoglycemia

Jaundice

Severe liver dysfunction

Please Note

Caution has to be exercised when prescribing Posmeal MD (Voglibose) in combination with the medications, listed below: